Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma. 2003

Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
Department of Oncological and Surgical Sciences, Clinica Chirurgica II, University of Padua, Italy. carlor.rossi@unipd.it

BACKGROUND Patients with peritoneal carcinomatosis from gastric carcinoma have a dismal prognosis. Hyperthermic intraperitoneal intraoperative chemotherapy (HIIC) has been proposed to treat residual disease after cytoreductive surgery. METHODS From January 1998 through July 2002, 13 patients with peritoneal carcinomatosis from gastric cancer underwent complete cytoreductive surgery followed by HIIC. Chemo-hyperthermia was performed using mitomicin C (3.3 mg/m2) and cisplatin (25 mg m2) for 90 minutes, at a mean intraperitoneal temperature of 41.7 degrees C. RESULTS No postoperative death was observed. Moderate locoregional toxicity (ileus) was observed in eight cases (42%), while two patients (10%) experienced mild systemic toxicity (myelosuppression or fever). Postoperative complication rate was 26% (pleural effusion, n = 4; septicemia = 1). Median overall survival was 15 months, and the median local progression free survival was 10 months. CONCLUSIONS Cytoreductive surgery followed by HIIC resulted a feasible procedure, the overall morbidity rate being acceptable. Although the study was conducted in a subset of patients with peritoneal carcinomatosis from gastric cancer (resectable disease), survival results are encouraging.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
November 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
June 2013, The American surgeon,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
August 2005, Journal of surgical oncology,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
December 2013, Journal of surgical oncology,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
November 2007, Journal of surgical oncology,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
February 2022, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
December 2010, The British journal of surgery,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
October 2018, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
October 2008, Annals of surgical oncology,
Carlo Riccardo Rossi, and Pierluigi Pilati, and Simone Mocellin, and Mirto Foletto, and Carlo Ori, and Federico Innocente, and Donato Nitti, and Mario Lise
March 2012, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!